As antibiotic resistance grows, so does research toward preventing and treating Clostridioides difficile, a bacterium known to be one of the leading causes of healthcare-associated infections in U.S. patients that can sometimes turn fatal. Often, infections from it occur while a patient is on antibiotics or shortly after they have finished a course.
Read the full post on Becker's Hospital Review - Healthcare News
